Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy
Isabella Giacomini, Federico Gianfanti, María Andrea Desbats, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression
Zhenzhen Pan, K. Wang, Xiniao Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 82
Single-cell spatial metabolomics with cell-type specific protein profiling for tissue systems biology
Thomas Hu, Mayar Allam, Shuangyi Cai, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Cholesterol metabolism in tumor immunity: Mechanisms and therapeutic opportunities for cancer
Xiaojia Guo, Bobo Zhu, Jing Li, et al.
Biochemical Pharmacology (2025), pp. 116802-116802
Closed Access | Times Cited: 2
Hallmarks of Metabolic Reprogramming and Their Role in Viral Pathogenesis
Charles Allen, Sterling P. Arjona, Maryline Santerre, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 602-602
Open Access | Times Cited: 43
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Rajni Kant, Rajesh Manne, Mohammad Anas, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1158-1174
Open Access | Times Cited: 34
Cholesterol: An important actor on the cancer immune scene
Hossein Halimi, Shirin Farjadian
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Mechanoregulatory Cholesterol Oxidase‐Functionalized Nanoscale Metal–Organic Framework Stimulates Pyroptosis and Reinvigorates T Cells
Wenyao Zhen, Taokun Luo, Zitong Wang, et al.
Small (2023) Vol. 19, Iss. 52
Open Access | Times Cited: 21
Effect of the Lipid Landscape on the Efficacy of Cell-Penetrating Peptides
Florina Zákány, István M. Mándity, Zoltán Varga, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1700-1700
Open Access | Times Cited: 18
Different Roles of Tocopherols and Tocotrienols in Chemoprevention and Treatment of Prostate Cancer
Qing Jiang
Advances in Nutrition (2024) Vol. 15, Iss. 7, pp. 100240-100240
Open Access | Times Cited: 7
It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases
Tamás Kovács, Florina Zákány, Péter Nagy
Cancers (2022) Vol. 14, Iss. 4, pp. 944-944
Open Access | Times Cited: 27
Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
Linsong Tang, Rongli Wei, Ronggao Chen, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 4402-4414
Open Access | Times Cited: 26
Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression
Giorgia Centonze, Dora Natalini, Alessio Piccolantonio, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Surface cholesterol-enriched domains specifically promote invasion of breast cancer cell lines by controlling invadopodia and extracellular matrix degradation
Mauriane Maja, Danahé Mohammed, Andra C. Dumitru, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 23
The role of cholesterol metabolism in tumor therapy, from bench to bed
Wenhao Xia, Hao Wang, Xiaozhu Zhou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies
Tasvi Daya, Andrea Breytenbach, Liang Gu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2024) Vol. 1870, Iss. 2, pp. 159578-159578
Open Access | Times Cited: 5
Prostate Cancer—Focus on Cholesterol
Lucija Škara, Ana Huđek, Ivan Pezelj, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4696-4696
Open Access | Times Cited: 32
Unveiling the Therapeutic Potential of Squalene Synthase: Deciphering Its Biochemical Mechanism, Disease Implications, and Intriguing Ties to Ferroptosis
David Figueredo Picón, Rachid Skouta
Cancers (2023) Vol. 15, Iss. 14, pp. 3731-3731
Open Access | Times Cited: 12
Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2
Marek Samec, Alena Mazuráková, Vincent Lučanský, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175655-175655
Closed Access | Times Cited: 11
Inhibition of PCSK9: a promising enhancer for anti-PD-1/PD-L1 immunotherapy
Shengbo Sun, Jingxin Ma, Tingting Zuo, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 4
Advances of nanomedicine targeting the interface of cholesterol metabolism and immune evasion
Chengying Wang, Bohan Chen, Yuming Wang, et al.
Chinese Chemical Letters (2025), pp. 110921-110921
Closed Access
Navigating Metabolic Challenges in Ovarian Cancer: Insights and Innovations in Drug Repurposing
Sara Mikhael, Georges Daoud
Cancer Medicine (2025) Vol. 14, Iss. 4
Open Access
Optimizing Model Performance and Interpretability: Application to Biological Data Classification
Zhenyu Huang, Xuechen Mu, Yangkun Cao, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 297-297
Open Access
Phytochemical Inhibitors of Squalene Epoxidase: Integrated In silico and In vitro Mechanistic Insights for Targeting Cholesterol Biosynthesis
Emadeldin M. Kamel, Doaa A. Abdelrheem, Bashir Salah, et al.
Archives of Biochemistry and Biophysics (2025) Vol. 768, pp. 110372-110372
Closed Access
Spatial genomics reveals cholesterol metabolism as a key factor in colorectal cancer immunotherapy resistance
Andrew J. Kavran, Yulong Bai, Brian Rabe, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Impaired Cellular Cholesterol Homeostasis Decreases Tumor-Derived Exosome Load And Modulates Malignant Transformation in Cancer Cells
Syed Sultan Beevi, Aishwarya Sudam Bhale, Vinod Kumar Verma, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Page 1 - Next Page

Scroll to top